Crossmark

Unresectable stage III non-small cell lung cancer: Insights from a Portuguese expert panel

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2022.11.008

Published Online: 2025-03-10

Published Print: 2024-03-30

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Araújo, A. https://orcid.org/0000-0002-7267-3584
Barroso, A.

Parente, B.

Travancinha, C.

Teixeira, E.

Martelo, F.

Fernandes, G.

Paupério, G.

Queiroga, H.

Duarte, I.

da Costa, J.D.

Soares, M. https://orcid.org/0000-0002-6071-3673
Borralho, P.

Costa, P.

Chinita, P.

Almodôvar, T.

Barata, F.
Funding

Funding for this research was provided by:

AstraZeneca
License Information

Version of Record valid from 2024-03-30
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tpul20

Publication History

Received: 2021-11-08

Accepted: 2022-11-29

Published: 2025-03-10